Effective against acne: tpSkin for easy support of skin health

Garching near Munich, May 12, 2023 – ESA has given the green light for the latest research project of terraplasma, the innovation leader in the development and implementation of applications with   cold   atmospheric plasma (Cold Plasma for short).  As part of the ESA Spark Funding program, the company received support for the development  of a device that uses a new, specially designed coldplasma  to provide an effective and sustainable treatment of acne  and other skin diseases and irritations.

Acne – widespread skin condition of youth

With a probability of occurrence of almost 100 percent, acne is the number one skin infection in adolescence and puberty. While a majority  of 60  percent  of  cases are mild acne that can be treated with non-prescription drugs, the remaining 40 percent are  acute or even chronic cases that require medical attention. The latter type of acne often presents a therapeutic challenge, as it is associated with acute lesions (destroyed cell tissue), severe inflammation and rapid scarring. In addition, patients with acne often suffer from low self-esteem, reduced quality of life and depression.

Cost factor acne-prone skin

In addition to this dermatological and psychological burden, acne also puts a financial strain on patients. An individual acne treatment (this only includes acne products but no professional medical care) costs about € 1,000 per year. On the other hand, the costs charged to the healthcare provider average €690 (up to €870) per acute acne period, including inpatient stays, outpatient services, emergency care and pharmacy costs during the episode.

Cold plasma against hard-to-reach acne bacteria

Acne infections are mainly caused by the anaerobic bacterium Cutibacterium acnes. Therefore, the device developed by terraplasma  will produce cold plasma, which  is able to efficiently inactivate these bacteria, which are mainly found in follicles and pores (and are therefore difficult to reach with creams and liquids), without damaging the surrounding healthy tissues.

Cold plasma makes the skin open to creams, medications and healing

Another goal is to design the cold plasma in such a way that it improves the absorption of antibacterial creams and liquids and is effective against other skin diseases and irritations.    Initial preliminary investigations have shown very positive results when using cold plasma on the skin: on the one hand, the cold plasma ensures that the regeneration of the skin cells is stimulated and, on the other hand, the skin pores are opened – this means that creams, but also externally administered medications can be better absorbed.

Ambitious goals with successful signs

In order to achieve all these goals, terraplasma will build  on  the extensive practical knowledge already gained by the company in the development of the successful  plasma care® for professional wound treatment and plasma derma care®® for the professional treatment of skin diseases.

As part of the funding program, the new  device from terraplasma (working title tpSkin) will be developed primarily for use by end users with the following core properties:

  • Transferable: no cables or hoses and battery operation with charging by induction
  • Practical: small, handy and can be used in one-handed operation
  • Simple: uncomplicated operation by medical laymen possible
  • kompakt: Use of new low-line plasma source based on SMD (Surface Micro-Discharge) technology
  • Innovative: newly developed, bactericidal plasma, which is gentle on the tissue in addition to combating acne and improves cream absorption
  • Tenable: only air and electricity are needed for plasma production

Terraplasma is confident that it will be able to intensively test the new device with  the first prototypes at the end of the year  as part of this funding program. Special attention is also paid to the compact size and cost of the device, which should be convincing in commercial form – terraplasma is still looking for a partner for marketing – not only because of its effectiveness.

tpSkin 003
tpSkin 002
Press release

Effective against PFAS: terraplasma successfully tests its own cold plasma technology for water treatment

Successful initial attempts to treat drinking water contaminated with PFAS: this is how terraplasma, the innovation leader in the area of development and implementation of applications with cold atmospheric plasma (in short: cold plasma or cold plasma), succeeded with its self-developed energy-saving cold plasma technology for water treatment alongside other substances such as For example, microorganisms and PFAS can be significantly reduced in a measurable way. In a first, larger series of tests with real water samples from a southern Bavarian PFAS hotspot, some of the so-called “forever chemicals” were reduced by up to almost 30%. Reason enough for the company to further optimize its technology and, together with potential partners, develop it into a ready-made solution for water treatment.

Read more »
Short Notice

Impressions from analytica 2024

analytica 2024 – it was an honor for us. A very well-informed trade audience, great and friendly stand staff and super fast service at the joint stand of Bayern Innovativ GmbH as well as intensive demand as to how we at terraplasma GmbH put our motto “replacing chemicals. the sustainable way.” into practice. Many thanks to everyone who visited, questioned and supported us at the trade fair – see you there.

Read more »
Press release

Cold plasma: terraplasma shows sustainable innovations in Berlin and Munich

“replacing chemicals. the sustainable way.” Under this motto, the innovation leader from Garching near Munich promotes the many different possible uses of cold plasma technology. Cold plasma is perfect for replacing conventional disinfection solutions with chemicals, UV, heat or radiation, for example, and thus enables true sustainability. In order to be able to show this to as many interested customers as possible, terraplasma is going to several trade fairs this year.

Read more »

Subscribe to our newsletter

Do not miss any more news about Cold Plasma
and subscribe to our newsletter.